Marker of T‐cell activation is elevated in refractory Kawasaki disease
Authors:
- 4 May 2010
- journal article
- research article
- Published by Wiley in Pediatrics International
- Vol. 52 (5) , 785-789
Abstract
Background: The aim of this study was to investigate whether T‐cell activation is involved in the pathogenesis of Kawasaki disease (KD) resistant to intravenous immunoglobulin (IVIG) treatment.Methods: Serum samples were obtained from 27 patients who fulfilled the diagnostic criteria for KD. These 27 patients were divided into three groups according to their responses to IVIG: Group A, nine patients who showed no response to either initial IVIG or additional IVIG; Group B, six patients who did not respond to initial IVIG but did respond to additional IVIG; Group C, 12 patients who responded to initial IVIG. Serum samples were obtained before and after initial IVIG. Using a commercial chemiluminescence enzyme immunoassay, we examined the serum levels of two cytokines related to T‐cell activation and the severity of inflammation: soluble interleukin‐2 receptor and interleukin‐6.Results: There were no significant differences in the serum levels of the two cytokines before initial IVIG among the three groups, but significant intergroup differences were evident after initial IVIG in the serum levels of soluble interleukin‐2 receptor (P < 0.01, Group A > C) and interleukin‐6 (P < 0.01, Group A > B > C).Conclusions: Our results show that marker of T‐cell activation is elevated most markedly in KD patients resistant to both initial and additional IVIG, and suggest that T cells may be activated in refractory KD.Keywords
This publication has 20 references indexed in Scilit:
- Detection of Multiple Superantigen Genes in Stools of Patients with Kawasaki DiseaseThe Journal of Pediatrics, 2009
- ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysmsNature Genetics, 2007
- Gene-expression patterns reveal underlying biological processes in Kawasaki diseaseGenome Biology, 2007
- T cell activation profiles in Kawasaki syndromeClinical and Experimental Immunology, 2007
- Anticytokine Therapy in Autoimmune Diseases.Internal Medicine, 1999
- The Role of T Cells in Kawasaki DiseaseCritical Reviews in Immunology, 1995
- Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-α and interleukin 6 in serumEuropean Journal of Pediatrics, 1992
- Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesionsClinical Immunology and Immunopathology, 1990
- Serum-soluble interleukin-2 receptor levels in Kawasaki diseaseThe Journal of Pediatrics, 1990
- Enhancement of the interleukin 2 receptor expression on T cells by multiple B-lymphotropic lymphokinesImmunology Letters, 1987